Why is Nectar Lifesci. falling/rising?

As of 23-Jul, Nectar Lifescience Ltd is experiencing a decline in its stock price, currently at 17.60, which reflects a decrease of 0.14 or 0.79%. The stock has underperformed its sector by 1.3% today and has been on a downward trend for the last two days, resulting in a total drop of 4.09% during this period. Over the past week, the stock has decreased by 3.14%, and it has shown a significant decline of 14.73% over the past month. The company's financial health is concerning, with a negative EBITDA and a high debt-to-EBITDA ratio of 7.73 times, indicating a weak ability to service its debt. Additionally, the company's profit after tax has fallen drastically, and 99.6% of promoter shares are pledged, which adds further downward pressure on the stock.
In the broader market context, the Sensex has shown a slight increase of 0.11% over the past week, contrasting with Nectar Lifescience's negative performance. The stock has consistently underperformed against the benchmark over the last three years, with a one-year return of -38.99% compared to the Sensex's gain of 2.86%. This consistent underperformance, coupled with falling investor participation and liquidity issues, suggests a lack of confidence among investors, further contributing to the stock's decline.